Loading clinical trials...

COMPLETEDPhase 1NCT03958864

A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Dose CC-90001 in Japanese and Caucasian Healthy Subjects

This is a Phase 1, open-label, randomized, parallel design study to evaluate the PK and safety/tolerability of CC 90001 in Japanese and Caucasian healthy adult subjects. The study will consist of mul...

Lead sponsor: Celgene•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Cytapheresis of Volunteer Donors

NCT00104325 · Healthy Volunteers

RECRUITINGPhase 1/2

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause

NCT07118891 · Vasomotor Symptoms Associated With Menopause, Healthy Volunteers

RECRUITINGPhase 1

Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers

NCT03878121 · Healthy Volunteer

RECRUITINGNA

New Heart Imaging Techniques to Evaluate Possible Heart Disease

NCT01399385 · Healthy, Obesity, and more

RECRUITINGPhase 1

A Study to Evaluate ALN-4285 in Adult Healthy Volunteers

NCT07295717 · Healthy Volunteers

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 8, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment60

Start dateApr 2019

Last updatedMay 8, 2020

Condition

Healthy Volunteer

Locations shown

Paraxel International

Glendale, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 8, 2020Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions